Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Non-GAAP Research and development expenses by Year
Non-GAAP Research and development expenses ($M) ($M)
Gilead Sciences Non-GAAP Research and development expenses: $5,687M in FY2025, down 0.8% from a year earlier.
Where the FY2025 figure comes from
“|| Research and development expenses | $ | 1,565 | $ | 1,612 | (3)% | $ | 5,687 | $ | 5,732 | (1)%”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗
Reported in Form 8-K Reconciliation of GAAP to Non-GAAP Financial Information.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Research and development expenses ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,687 | -0.8% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2024 | Dec 31, 2024 | 5,732 | +0.2% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2023 | Dec 31, 2023 | 5,720 | +15.1% | Form 8-K (exhibit991earningspressrel.htm, filed 2025-02-11) ↗ |
| FY2022 | Dec 31, 2022 | 4,968 | +11.3% | Form 8-K (exhibit991earningspressrel.htm, filed 2024-02-06) ↗ |
| FY2021 | Dec 31, 2021 | 4,464 | -8.1% | Form 8-K (exhibit991earningspressrel.htm, filed 2023-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 4,857 | +19.7% | Form 8-K (exhibit991earningspressrel.htm, filed 2022-02-01) ↗ |
| FY2019 | Dec 31, 2019 | 4,059 | +15.4% | Form 8-K (exhibit991earningspressrel.htm, filed 2021-02-04) ↗ |
| FY2018 | Dec 31, 2018 | 3,518 | +6.9% | Form 8-K (exhibit991earningspres.htm, filed 2020-02-04) ↗ |
| FY2017 | Dec 31, 2017 | 3,291 | -12.2% | Form 8-K (exhibit991earningspressrel.htm, filed 2019-02-04) ↗ |
| FY2016 | Dec 31, 2016 | 3,749 | – | Form 8-K (gildq42017exh991.htm, filed 2018-02-06) ↗ |
Breakdown
What makes up non-GAAP Research and development expenses
Cite this data
StockData. (2026). Gilead Sciences Non-GAAP Research and development expenses ($M), annual FY2016–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rd-nongaap-tot
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.